Telomir Pharmaceuticals, Inc. (TELO)

NASDAQ: TELO · IEX Real-Time Price · USD

3.878

+0.128 (3.41%)

Jul 22, 2024, 9:51 AM EDT - Market open

Telomir Pharmaceuticals Employees

As of December 31, 2023, Telomir Pharmaceuticals had 9 total employees, including 1 full-time and 8 part-time employees.

Employees

9

Change

n/a

Growth

n/a

Revenue / Employee

n/a

Profits / Employee

-$2,093,726

Market Cap

117.25M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	9	-	-

Related Stocks

Company Name	Employees
Augmedix	1,430
FONAR	561
Karyopharm Therapeutics	325
TELA Bio	227
I-Mab	220
Adagene	174
RAPT Therapeutics	131
KORU Medical Systems	82

Employee Rankings

TELO News

20 days ago - Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap Indexes - GlobeNewsWire
4 weeks ago - Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel - GlobeNewsWire
7 weeks ago - Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1 - GlobeNewsWire
3 months ago - Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C. - GlobeNewsWire
3 months ago - Telomir Pharmaceuticals' Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024 - GlobeNewsWire
4 months ago - UPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines - GlobeNewsWire
4 months ago - Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines - GlobeNewsWire
4 months ago - Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26th - GlobeNewsWire